D. E. Shaw & Co., Inc. Medpace Holdings, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $125 Billion
- Q2 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 343,563 shares of MEDP stock, worth $187 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
343,563
Previous 214,178
60.41%
Holding current value
$187 Million
Previous $65.3 Million
65.24%
% of portfolio
0.09%
Previous 0.07%
Shares
32 transactions
Others Institutions Holding MEDP
# of Institutions
666Shares Held
27MCall Options Held
53.6KPut Options Held
108K-
Black Rock Inc. New York, NY2.58MShares$1.4 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.39MShares$1.3 Billion0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT946KShares$515 Million1.61% of portfolio
-
Mawer Investment Management Ltd. Calgary, A0817KShares$445 Million1.35% of portfolio
-
State Street Corp Boston, MA707KShares$385 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $16.9B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...